Profil bibliographique

Mitchell Edelson

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées

5Citations signalées

2Affiliations récentes

Institutions déclarées

Abington Memorial Hospital Jefferson Hospital

Domaines associés

PARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentCancer-related Molecular PathwaysEndometrial and Cervical Cancer TreatmentsAdvanced Breast Cancer Therapies

Publications récentes

2026 articleOpenAlex

Four-year survival outcomes with dostarlimab plus chemotherapy in dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Matthew Powell, Oleksandr Zub, Lucy Gilbert, Anthoula Koliadi et autres

2 citationsGynecologic Oncology

2026 conference-abstractOpenAlex

GOG-3039: A phase II trial of abemaciclib plus letrozole in recurrent or persistent endometrioid endometrial carcinoma (NCT04393285)

Marilyn Huang, Gloria Huang, J. Matt Pearson, Sarah Gill et autres

0 citationsGynecologic Oncology

2026 articleOpenAlex

Exploratory analysis of ribociclib plus letrozole in recurrent low-grade serous ovarian carcinoma: Impact of prior therapy, chemotherapy exposure, and age (GOG-3026)

Vivek Podder, Robert Coleman, Wei Deng, John Weroha et autres

0 citationsGynecologic Oncology

2026 conference-abstractOpenAlex

Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair–deficient or microsatellite instability–high primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Matthew Powell, Oleksandr Zub, Lucy Gilbert, Anthoula Koliadi et autres

0 citationsNCODA Oncology and Hematology Meeting Abstracts

2025 articleOpenAlex

FINAL OVERALL SURVIVAL RESULTS FROM THE GOG281/LOGS STUDY EVALUATING TRAMETINIB VERSUS PHYSICIAN’S CHOICE STANDARD-OF-CARE THERAPY FOR RECURRENT LOW-GRADE SEROUS OVARIAN CANCER (LGSOC)

Charlie Gourley, A. Austin Miller, Karen Carty, William H. Rodgers et autres

0 citationsInternational Journal of Gynecological Cancer

2025 articleOpenAlex

Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Mansoor Mirza, Lyndsay Willmott, Sakari Hietanen, Lucy Gilbert et autres

1 citationGynecologic Oncology

Accès ouvert 2025 articleOpenAlex

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Lindsay Kuroki, Danielle Enserro, Heather A. Lankes, Kyle C. Strickland et autres

0 citationsGynecologic Oncology

Accès ouvert 2024 articleOpenAlex

Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over

Omali Pitiyarachchi, Peter Ansell, Robert L Coleman, Minh H. Dinh et autres

2 citationsGynecologic Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.